Cited by 414Hippo pathway signaling and YAP/TAZCancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

Aerobic glycolysis tunes YAP/TAZ transcriptional activity

Open access
Enzo, Elena, Santinon, Giulia, Pocaterra, Arianna, Aragona, Mariaceleste, Bresolin, Silvia, Forcato, Mattia, Grifoni, Daniela, Pession, Annalisa +4 more·2015·The EMBO Journal

Abstract

Increased glucose metabolism and reprogramming toward aerobic glycolysis are a hallmark of cancer cells, meeting their metabolic needs for sustained cell proliferation. Metabolic reprogramming is usually considered as a downstream consequence of tumor development and oncogene activation; growing evidence indicates, however, that metabolism on its turn can support oncogenic signaling to foster tumor malignancy. Here, we explored how glucose metabolism regulates gene transcription and found an unexpected link with YAP/TAZ, key transcription factors regulating organ growth, tumor cell proliferation and aggressiveness. When cells actively incorporate glucose and route it through glycolysis, YAP/TAZ are fully active; when glucose metabolism is blocked, or glycolysis is reduced, YAP/TAZ transcriptional activity is decreased. Accordingly, glycolysis is required to sustain YAP/TAZ pro-tumorigenic functions, and YAP/TAZ are required for the full deployment of glucose growth-promoting activity. Mechanistically we found that phosphofructokinase (PFK1), the enzyme regulating the first committed step of glycolysis, binds the YAP/TAZ transcriptional cofactors TEADs and promotes their functional and biochemical cooperation with YAP/TAZ. Strikingly, this regulation is conserved in Drosophila, where phosphofructokinase is required for tissue overgrowth promoted by Yki, the fly homologue of YAP. Moreover, gene expression regulated by glucose metabolism in breast cancer cells is strongly associated in a large dataset of primary human mammary tumors with YAP/TAZ activation and with the progression toward more advanced and malignant stages. These findings suggest that aerobic glycolysis endows cancer cells with particular metabolic properties and at the same time sustains transcription factors with potent pro-tumorigenic activities such as YAP/TAZ.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.201490379

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PFK1 directly binds to and regulates YAP and TAZ.

    “In another study, the Dupont group showed that the glycolytic enzyme phosphofructokinase ( PFK1 ) directly binds to and regulates YAP and TAZ (36).”

    From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [36]

    The paper reports that PFK1 knockdown inhibited YAP/TAZ activity, supporting the regulation part of the claim. But in its discussion of YAP interaction (page not supplied), the authors say they could hardly detect direct PFK1–YAP binding; they instead found that PFK1 binds TEAD proteins. The claimed direct binding to YAP and TAZ is therefore not supported. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Both glucose starvation and AMPK activators inhibit Yap in different cell types.

    “Both glucose starvation (36, 100, 145) and AMPK activators (26, 100, 145) inhibit Yap in different cell types.”

    From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [36]

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Elena Enzo et al Glycolysis tunes YAP/TAZ activity The EMBO Journal
  2. Yang Y, Lane AN, Ricketts CJ, Sourbier C, Wei M-H, Shuch B, Pike L, Wu M, Rouault TA, Boros LG, Fan TWM, Linehan WM (2013) Metabolic ª 2015 The Authors The EMBO Journal Vol 34 | No 10 | 2015

Cited by

Sorted by citations

Authors
Enzo, E., Santinon, G., Pocaterra, A., Aragona, M., Bresolin, S., Forcato, M., Grifoni, D., Pession, A., Zanconato, F., Guzzo, G., Bicciato, S., & Dupont, S.
Affiliations
  • University of Padua (IT)
  • University of Modena and Reggio Emilia (IT)
  • University of Bologna (IT)
Corresponding author
Dupont, Sirio
Venue
The EMBO Journal
Published
2015-03-21
Volume
34
Issue
10
Pages
1349-1370
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2168636113
Cited by
414
References
112
Citations by year
2026: 23 · 2025: 41 · 2024: 49 · 2023: 39 · 2022: 54 · 2021: 46 · 2020: 41 · 2019: 42 · 2018: 42 · 2017: 11 · 2016: 17 · 2015: 8
FWCI
13.86
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, public-domain)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
  • AIRC (IG15307)
  • MIUR/PRIN
  • PRAT University of Padova
  • FIRB Accordi di Programma 2011 (RBAP11T3WB)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
aerobic glycolysis, YAP/TAZ, TEAD transcription factors, phosphofructokinase-1, glucose metabolism, tumor metabolic reprogramming, transcriptional regulation, breast cancer, Yki, tumor progression, oncogenic signaling
MeSH terms
YAP-Signaling Proteins, Acyltransferases, Animals, Bacteria, Aerobic, Drosophila, Glycolysis, Humans, Phosphoproteins, Transcription Factors, Cell Line, Tumor, Chromatin Immunoprecipitation, Immunoprecipitation, Adaptor Proteins, Signal Transducing, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review